nasopharyngeal carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. NPC patients confirmed by pathology (including keratinized squamous cell carcinoma, non-keratinized differentiated NPC, and non-keratinized undifferentiated NPC); 2. Confirmation of untreated, non-newly diagnosed metastatic NPC by radiologic evaluation; 3. Receiving standard treatment based on IMRT; 4. No history of other malignant tumors; 5. Male or female, older than 18 years old; 6. No serious heart, lung and other important organ dysfunction; 7. Eastern Cooperative Oncology Group (ECOG) score <= 2; 8. Serum EBV DNA records before and after treatment and during follow-up were complete, and relevant follow-up data were complete.
Exclusion criteria
Exclusion criteria: 1. Patients who cannot cooperate with regular follow-up due to psychological, social, family and geographical reasons; 2. Concurrently receiving investigational treatment in other clinical studies (in the treatment phase of the clinical study); 3. Patients with severe uncontrolled infection, medical diseases, or known primary immunodeficiency diseases; 4. Important organ dysfunction, decompensated heart, lung, kidney, liver failure, unable to tolerate radiotherapy, chemotherapy, immunotherapy, etc. 6. Patients with incomplete data from diagnosis to receiving systemic treatment and follow-up period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive Predictive Value;Negative Predictive Value; | — |
Countries
China
Contacts
The First Affiliated Hospital of Xiamen University